EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions

Hideo Fukuhara iD, Hisham M Dokainish, Shunsuke Kita iD, Koshiro Tabata iD, Akira Takasu iD, Juha T Huiskonen iD, Yuki Anraku iD, Tomo Nomai iD, Taiyo Someya, Toshiya Senda iD, David I Stuart, Michihito Sasaki iD und 4 weitere

Protein Science · 2026-12 · 35 (12)

DOI: 10.1002/pro.70833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, online erschienen am 05.11.2026. Verfasst von Hideo Fukuhara und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathogen Structure, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Cryoelectron Microscopy, Electron Microscope Tomography, SARS-CoV-2, Virion. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Global Institution for Collaborative Research and Education, Hokkaido University, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the structural properties of pathogenic viruses in their native, infectious state is critical for rational vaccine and drug development. However, conducting cryo‐electron microscopy (cryo‐EM) under biosafety level 3 (BSL‐3) containment presents significant challenges. Here, we established and validated a high‐end cryo‐EM workflow within a BSL‐3 facility, comprehensively integrating facility design, containment measures, sample handling, cryo‐transfer systems, and decontamination protocols. To demonstrate the utility and reproducibility of this workflow, we applied cryo‐electron tomography to investigate severe acute respiratory syndrome coronavirus 2 in its native, active state. Our observations confirm that unfixed viral particles display pleomorphic features comparable to those previously reported in fixed or inactivated preparations, validating that these structural characteristics represent native features rather than artifacts of chemical fixation. Furthermore, spatial redistribution of surface spikes was observed. The establishment of this robust BSL‐3 cryo‐EM workflow provides a practical blueprint for the structural characterization of emerging high‐consequence pathogens, supporting pandemic preparedness, vaccine development, and antiviral discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryoelectron MicroscopyElectron Microscope TomographySARS-CoV-2VirionContainment of BiohazardsAnimalsHumansCOVID-19

Stichwörter der Autor:innen

SARS‐CoV‐2cryo‐ETnative active virionsspike proteinvaccine design

Autor:innen und Institutionen

  • Division of Pathogen Structure, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo, Japan.
  • Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.
  • Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
  • Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.

ORCID-Profile: Hideo Fukuhara, Shunsuke Kita, Koshiro Tabata, Akira Takasu, Juha T Huiskonen, Yuki Anraku, Tomo Nomai, Toshiya Senda, Michihito Sasaki, Yasuko Orba, Yasuhiko Suzuki, Hirofumi Sawa, Katsumi Maenaka

Förderung

  • Japan Agency for Medical Research and Development
  • Global Institution for Collaborative Research and Education, Hokkaido University
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science
  • Ministry of Health, Labour and Welfare
  • Takeda Science Foundation

Zitieren

APA

Fukuhara, H., Dokainish, H. M., Kita, S., Tabata, K., Takasu, A., Huiskonen, J. T., Anraku, Y., Nomai, T., Someya, T., Senda, T., Stuart, D. I., Sasaki, M., Orba, Y., Suzuki, Y., Sawa, H., & Maenaka, K. (2026). Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions. Protein Science, 35(12). https://doi.org/10.1002/pro.70833

Vancouver

Fukuhara H, Dokainish HM, Kita S, Tabata K, Takasu A, Huiskonen JT, et al. Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions. Protein Science. 2026;35(12). doi:10.1002/pro.70833

BibTeX
@article{Fukuhara2026,
  author = {Fukuhara, Hideo and Dokainish, Hisham M and Kita, Shunsuke and Tabata, Koshiro and Takasu, Akira and Huiskonen, Juha T and Anraku, Yuki and Nomai, Tomo and Someya, Taiyo and Senda, Toshiya and Stuart, David I and Sasaki, Michihito and Orba, Yasuko and Suzuki, Yasuhiko and Sawa, Hirofumi and Maenaka, Katsumi},
  title = {Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions},
  journal = {Protein Science},
  year = {2026},
  volume = {35},
  number = {12},
  doi = {10.1002/pro.70833}
}
Kostenlos starten →